Eon crashes the party

When SangStat Medical Corp.'s SangCya cyclosporine liquid solution was approved in 1998, the primary issue was how the product would fare against Novartis AG's Neoral cyclosporine capsules. Coupled with subsequent legal action by NOVN against both SANG and the FDA, it was easy to overlook a third

Read the full 479 word article

How to gain access

Continue reading with a
two-week free trial.